The National Medical Products Administration has issued an announcement on the release of several regulations to support the innovation of cosmetic raw materials.
National Medical Products Administration unveils groundbreaking policy to drive raw material innovation, offering new opportunities for brands, researchers, and investors
Explore how the NMPA's latest draft opinion could open doors for cruelty-free cosmetic brands in China, potentially transforming market access strategies.
Uncover the complexities of China's nanomaterial regulations and their impact on innovative cosmetic ingredients like exosomes in this essential analysis for industry professionals.
Discover how aligning cosmetic testing protocols between China and the EU/UK can significantly reduce time and costs for market entry, optimizing your global expansion strategy.
Outline safety assessment guidelines for specific cosmetic ingredients in China, focusing on special consideration due to unique properties or potential risks.
Explore the details of China's drug instruction and labeling requirements to ensure regulatory compliance and optimize patient safety in the world's second-largest pharmaceutical market.
Dive deep into China's OTC drug registration process, exploring overseas clinical trial acceptance, first-in-market opportunities, and local testing requirements. Gain crucial insights for successful market entry and regulatory compliance in this comprehensive guide.
Dive deep into China’s drug registration process, exploring overseas clinical trial acceptance, first-in-market opportunities, and local testing requirements.
Outline comprehensive regulations for drug research, registration, and market authorization, ensuring safety, efficacy, and quality control across TCM, chemical drugs, and biological products.
